Filter
138
Text search:
antiviral
prophylaxis
in
pregnancy
Featured
Recommendations
28
New Publications
36
Language
Document type
No document type
75
Guidelines
40
Manuals
8
Studies & Reports
8
Strategic & Response Plan
4
Training Material
2
Fact sheets
1
Countries / Regions
Nepal
6
Kenya
6
South Africa
5
Zambia
4
Global
4
Nigeria
3
Uganda
3
India
3
Philippines
2
Tanzania
2
Rwanda
2
Bangladesh
2
Ukraine
2
Myanmar / Burma
2
Western and Central Europe
2
Asia
2
Russia
2
Ethiopia
1
Ghana
1
Zimbabwe
1
South Sudan
1
Germany
1
Cambodia
1
Malawi
1
Mozambique
1
Namibia
1
Eswatini/ Swaziland
1
North Macedonia
1
Latin America and the Carribbean
1
Albania
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
32
Public Health
7
Women & Child Health
4
Capacity Building
3
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
HIV
33
COVID-19
10
Pharmacy
10
Rapid Response
9
AMR
6
Ebola
4
Refugee
4
Natural Hazards
2
TB
2
Caregiver
2
Conflict
1
Zika
1
Mental Health
1
Specific Hazards
1
NTDs
1
NCDs
1
WPSAR Vol 8, No 4, 2017 | doi: 10.5365/wpsar.2017.8.3.005
DOI: http://dx.doi.org/10.5365/wpsar.v8i4.564
Joint Stakeholder Submission
Accessed: 29.09.2019
16.7.2021
(Last Update: July 2022)
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials
...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination
...
Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos
...
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
